Research Article
Determination of Early and Late Endothelial Progenitor Cells in Peripheral Circulation and Their Clinical Association with Coronary Artery Disease
Table 1
Clinical background of examined subjects.
| | Parameters | Control () | CAD () | value |
| | Male gender | 22 (61%) | 34 (72%) | n.s. | | Age (years) | 59 ± 14 | 67 ± 10 | n.s. | | Laboratory data | | | | | WBC (/L | 6710 ± 2654 | 5992 ± 1770 | n.s. | | Neutrophil (%) | 61 ± 12 | 63 ± 8 | n.s. | | Lymphocyte (%) | 30 ± 2 | 26 ± 9 | n.s. | | MDA-LDL/LDL-chol. | 1.05 ± 0.02 | 1.27 ± 0.11 | n.s. | | hs-CRP (mg/dL) | 0.10 ± 0.1 | 0.22 ± 0.3 | n.s. | | HbA1c (%) | 5.6 ± 0.5 | 5.9 ± 0.7 | n.s. | | Disease | | | | | Diabetes mellitus | 3 (8%) | 14 (30%) | <0.05 | | Hypertension | 3 (8%) | 21 (45%) | <0.05 | | Hyperlipidemia | 1 (3%) | 20 (43%) | <0.05 | | Medication | | | | | ARB or ACE-I | 4 (11%) | 22 (47%) | <0.05 | | CCB | 0 (0%) | 14 (30%) | <0.05 | | Statin | 1 (3%) | 20 (43%) | <0.05 |
|
|
ACE = angiotensin converting enzyme, ARB = angiotensin receptor blockage, CAD = coronary artery disease, and CCB = calcium channel blocker.
|
